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Abstract
Human Metapneumovirus (hMPV) is responsible for acute respiratory infections in humans,
with clinical and epidemiological relevance in pediatric, elderly, and immunocompromised
populations. These features are largely unknown in Córdoba, Argentina and in adults in gen-
eral. Hence, our goal was to broadly characterize hMPV infection in patients of all ages hos-
pitalized with acute respiratory infections in Córdoba, Argentina, including epidemiology,
clinical features and genetic diversity. Nasopharyngeal secretions were obtained from 795
patients during 2011–2013, 621 patients were 0–25 years old and 174 were 26–85 years
old. HMPV was assayed by RT-PCR and other respiratory viruses by indirect immunofluo-
rescence. Local strains were identified by sequence analysis. Human Metapneumovirus
was detected in 20.3% (161/795) patients, 13.1% as single infections and 7.2% in co-infec-
tions, more frequently with Respiratory Syncytial Virus. HMPV circulated during late winter
and spring in all age patients, but mainly in children under 4 years old in 71.4% (115/161)
and adults between 26 and 59 years old in 12.4% (20/161). The most prevalent diagnosis
was mild acute respiratory infection in 59.6% (96/161) and bronchiolitis in 9.3% (15/161).
Local strains were clustered within A2 subtype; they presented 73–100% identities among
them, showing a high degree of homology compared to isolations from neighboring coun-
tries. We demonstrate that hMPV circulated among all age patients with respiratory infection
during 2011–2013 in Córdoba, contributing to the understanding of this virus, its diagnosis
and patient handling in local health-care centers.
Introduction
Viruses responsible for acute respiratory infections (ARI) have a great impact on human health
and continue to emerge; in consequence, their diagnosis and surveillance constitute a mile-
stone for the Public Health system. Human Metapneumovirus (hMPV- Pneumoviridae family)
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was isolated for the first time by Van den Hoogen in The Netherlands (2001), who detected it
in respiratory samples of children younger than 5 years of age [1, 2].
The hMPV spherical particle has an envelope and its genome is constituted by a negative
single-stranded and not segmented RNA of 13.3-Kb long. It has 8 genes that encode for 9
proteins: nucleoprotein (N), phosphoprotein (P) large protein (L), matrix proteins (M, M21,
M22), and glycoproteins G (adhesion), F (fusion) and SH (small hydrophobic) [3–5].
Severe ARI caused by hMPV leading to hospitalization usually occur in children under 5
years are detected in 5–15% of the cases, representing the second most frequent viral cause of
ARI after respiratory syncytial virus (RSV). Primary infection with hMPV occurs during the
first 2 years of life and re-infections can occur repeatedly until adulthood [6, 7]. The infection
can be subclinical or associated with bronchiolitis, pneumonia and asthma exacerbation, espe-
cially in children. In children, hMPV infection can cause fever, runny nose, cough, pharyngitis,
otitis, wheezing and hypoxia [5, 8].
The virus also infects 4–5% of young adults, producing generally mild infections with
symptoms such as cough, nasal congestion, hoarseness, sore throat and fever [7, 8]. Neverthe-
less, older adults and immunocompromised patients may present more severe clinical mani-
festations [5] and those with chronic diseases constitute also a risk group since they can
undergo severe hMPV infection (4–13%), sometimes associated with fatal outcomes [5, 9, 10].
HMPV has been detected in single infections and in co-infections with other respiratory
pathogens, including rhinoviruses, RSV, parainfluenza virus (PIV), influenza (Flu), bocavirus,
and coronavirus [5, 7, 11].
This agent has a seasonal distribution; peaks have been reported at the end of winter and
during spring, after RSV and Flu. In temperate regions, hMPV co-circulates with PIV during
winter and until late spring [5, 8].
Phylogenetic analyses have demonstrated two hMPV genotypes: A and B; they are classified
into sub-genotypes 1 and 2 (A1, A2, B1, B2) [12]. The amino acid sequence of F protein shows
94–97% identity when comparing A and B lineages, and less than 98% between the subtypes
(A1 vs. A2 and B1 vs. B2), while the N gene is more conserved when comparing all subgeno-
types (91.2% and 98.4%) [7, 8, 13, 14]. Both genotypes can circulate simultaneously; the pre-
dominance of one or the other depends on the year and region. It has also been proposed that
different genotypes may produce infections with different degrees of severity [7, 8].
HMPV is widely distributed worldwide [8]. In Buenos Aires, Argentina, it has been
detected in 11% of children with ARI and subtypes A1, A2, and B1 were identified [15, 16]. In
contrast, in an early study carried out in our laboratory, in Córdoba, hMPV was detected in
4% of pediatric patients hospitalized with lower ARI [17]. In addition, the general epidemiol-
ogy of the virus and its impact in adults and the elderly is still unknown in Córdoba, where it is
not generally included in the differential diagnosis of respiratory diseases.
Here we describe epidemiological features, clinical, and molecular diversity of hMPV infect-
ing patients of all ages hospitalized due to ARI during 2011–3013 in Córdoba, Argentina. We
demonstrate that human Metapneumovirus circulated in all age patients during this period.
Materials and methods
Ethical considerations
This study complied with the principles outlined by the Declaration of Helsinki and was
approved by an independent Ethics Committee of Children Hospital "Santı́sima Trinidad"
(CIEIS Protocol: 05/2011). All participants included or their parents/legal guardians signed
a written informed consent prior to clinical specimen collection and the data were analyzed
anonymously.
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Study design and specimen collection
A prospective descriptive study was performed. Inclusion criteria: patients of all ages hospital-
ized with signs or symptoms related to ARI and/or a diagnosis of ARI, subjects from Córdoba
(capital of Córdoba province), and hospitalized from January 2011 through December 2013.
Exclusion criteria were patients with ambulatory treatment and hospitalization for other
causes than ARI.
The patients were evaluated by the physiologists, who considered their inclusion in the
study and invited them to participate. Clinical respiratory specimens were obtained by naso-
pharyngeal aspirate (NPA) or nasopharyngeal swab (NPS) according to age. The samples were
obtained from eight different hospitals of Córdoba.
Demographic, epidemiological, and clinical data of patients were recorded in ad-hoc forms,
including date, age, gender, preexisting medical conditions, signs and symptoms at the time of
hospitalization, and clinical diagnosis. The samples were collected according to established
clinical protocols and then delivered on ice to the Laboratory of Respiratory Viruses, Instituto
de Virologı́a "Dr. J. M. Vanella", Facultad de Ciencias Médicas, Universidad Nacional de Cór-
doba, for analysis.
Diagnostic panel for respiratory viruses
Samples were tested for Flu A and B, RSV, Adenovirus (AdV), and PIV 1–3 using an indirect
immunofluorescence (IF) assay (LIGHT DIAGNOSTICS™ Respiratory Viral Panel I Screening
Kit & Identification IFA. Temecula, CA, USA) according to the manufacturer’s instructions.
This is used for routine laboratory diagnosis in the clinical practice.
Human Metapneumovirus detection
Nucleic acids from all samples were extracted with the QIAamp1 Viral RNA Mini Kit (Qia-
gen, Hilden, Germany) following the manufacturer instructions. PCR for detection of hMPV
N gene was used to amplify a 199 bp fragment, using the Qiagen OneStep RT-PCR kit (Qiagen,
Hilden, Germany). The protocol for conventional RT-PCR was adapted from Bouscambert-
Duchamp [18]. This PCR was validated for hMPV diagnosis and was implemented in our lab-
oratory. We used the following hMPV primers: Fw 5´-GTGATGCACTCAAGAGATACCC-3´
and Rv 5´- CATTGTTTGACCGGCCCCATAA-3´, 50 μM each. Cycling conditions: 30 min at
50˚C and 15 min at 94˚C, followed by 40 cycles of 95˚C for 30 sec, 58˚C for 30 sec and 72˚C
for 1 min, plus one final step of 72˚C for 10 min. PCR products were separated by electropho-
resis on a 1.5% agarose gel and visualized under UV light after ethidium bromide staining.
Human Metapneumovirus genotyping
RT-PCR protocol was adapted from Van den Hoogen [19] to amplify a 696 bp fragment of F
gene, using the Qiagen OneStep RT-PCR kit (Qiagen, Hilden, Germany), with primer mix Fw
5´-CAATGCAGGTATAACACCAGCAATATC-3´ and Rv 5´-GCAACAATTGAACTGATCTT-
CAGGAAAC-3´, 50 ?M each. Cycling conditions: 30 min at 42˚C and 8 min at 95˚C, followed
by 40 cycles of 94˚C for 1 min, 40˚C for 2 min and 72˚C for 3 min, and a final step of 72˚C for
10 min. The amplified products were separated by electrophoresis on a 1.5% agarose gel and
visualized under UV light after ethidium bromide staining.
All PCR products were purified with QIAquick Gel Extraction Kit (Qiagen, Hilden, Ger-
many) according to the manufacturer’s instructions. Human MPV RNA high quality for
sequencing was selected. The nucleoprotein gene region (199 bp) and the fusion gene (696 bp)
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were subjected to direct nucleotide sequencing reactions in both directions using the internal
PCR primers by Macrogen, Inc. (Seoul, Korea).
The sequences obtained were edited with MEGA 4.0.2 [20] and independent alignments
were made for N and F gene with sequences available in the GenBank, using ClustalW.
Maximum likelihood trees (ML) were constructed with the PhyML 3.1 software [21]. The
branch support was evaluated via non-parametric bootstrapping with 1000 pseudoreplicates.
The nucleotide substitution model for each data set analyzed was selected according to the
Akaike information criteria implemented in the ModelTest 3.7 software [22].
The sequences used for phylogenetic analysis (GenBank) for N and F genes are shown in S1
Table. Sequences shorter than 200 bp (N gene) are available in S2 Table. F gene sequences
were deposited in GenBank (accession nos. MN136292, MN136293, MN136294, and
MN136295).
Data analysis and graphics
Data and graphics were prepared with Graph Pad Prism 5.0 (GraphPad Software, San Diego,
California, USA). The prevalence was expressed as percentage. The seasonal distribution of
hMPV, RSV, Flu A- B, AdV and PIV 1–3, was organized according to months (2011–2013).
For the age distribution of cases, patients were classified into 6 age-groups, which resulted in
the following sample sizes:�12 months = 378; 13 months to 4 years = 124; 5–14 years = 89;
15–25 years = 30; 26–59 years = 128 and� 60 years = 46. Categorical variables were compared
using the Two-tailed Chi-square test. P-value of<0.05 was considered statistically significant.
Results
In total, 795 patients ranging from 0 to 85 years old were enrolled in this study. Of them,
53.84% (428/795) were male, and 46.16% (367/795) female. The median age was 12 months
(IQR: 2–132), 621 samples corresponded to patients 0–25 years old and 174 samples to patients
26–85 years old.
Human Metapneumovirus prevalence
Of the 795 clinical specimens analyzed, 52.8% (420/795) resulted positive for respiratory
viruses (hMPV, Flu-A, Flu-B, RSV, AdV, and PIV 1–3), either in single or co-infections.
Human Metapneumovirus occurred in a ratio of 72:89 female to male patients, respectively.
The prevalence of hMPV was 20.3% (161/795), of which 65% (104/161) were single infections
and 35% (57/161) were double infections. Among double infections, the most frequent co-
infecting agent was RSV (35/57). RSV was the most prevalent virus, followed by hMPV and
Flu-A (Table 1).
Age distribution of hMPV cases
Human Metapneumovirus was detected in all age-groups studied. The median age of hMPV
positive patients was 12 month (IQR = 2–111), while hMPV was most prevalent in the group
of infants under 12 months (24.34%, 92/378), followed by patients 15–25 years (20%, 6/30),
children 13 months to 4 years old (18.55%, 23/124) and 5–14 years old (16.85%, 15/89).
In addition, it is worth noting that 15.62% (20/128) cases occurred in patients 26–59 years
old and 10.86% (5/46) were adults older than 60 years.
The most prevalent virus was RSV and 98% of the RSV positive samples corresponded to
children under 4 years of age. However, Flu A was more frequent in patients older than 15
years.
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Seasonal distribution of hMPV
Throughout the three years studied, hMPV circulated from autumn to late spring with a preva-
lence peak between July and August. As shown in Fig 1, hMPV circulation extended during
Table 1. Viral detection in hospitalized patients in single and co-infections (N = 795).
HOSPITALIZED
n % Prevalence (n = 795)





PIV 3 8 1
Flu-B 3 0.4
AdV 2 0.3
PIV 1 2 0.3
Double infection 61 7.7
hMPV- RSV 35 4.4
hMPV- Flu-A 16 2.0
hMPV- PIV 3 3 0.4
hMPV- AdV 1 0.1
hMPV- Flu-B 2 0.3
RSV-PIV 3 2 0.3
RSV- Flu A 2 0.3
hMPV: Human Metapneumovirus; Flu A: Influenza Virus A; Flu B: Influenza Virus B; RSV: Respiratory Syncytial
Virus; AdV: Adenovirus; PIV: Parainfluenza Virus.
https://doi.org/10.1371/journal.pone.0244093.t001
Fig 1. Seasonal distribution of hMPV. Seasonal distribution of hMPV, RSV, Flu A, Flu B, AdV, PIV 1–3 during
2011–2013 in Córdoba, Argentina. The distribution is sorted by month. (n = 795). hMPV: Human Metapneumovirus.
Flu: Influenza. AdV: Adenovirus. PIV: Parainfluenza virus.
https://doi.org/10.1371/journal.pone.0244093.g001
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the spring months, after the winter outbreaks of Flu A and RSV. In 2011 and 2012 hMPV cases
were detected even during November and December (late spring).
Clinical presentation of hMPV in single and co-infection
The most frequent signs/symptoms in all patients infected with respiratory viruses were fever,
cough, sore throat, headache, and weakening. In hMPV positive patients the most frequent
symptoms were fever, cough, and headache.
Regarding the clinical evaluation of hMPV infected patients, 59.6% (96/161) were hospital-
ized for breathing difficulty and with a diagnosis of mild ARI. Other frequent respiratory dis-
eases were bronchiolitis in 9.31% (15/161) cases and pneumonia of viral etiology in 3.72% (6/
161). Also, 4.35% (7/161) hMPV infected patients were admitted for respiratory difficulty syn-
drome (RDS) and recurrent bronchial obstruction (RBO), and 3.72% (6/161) for asthmatic cri-
sis or asthma exacerbation. We compared the clinical presentation of patients with hMPV
single detection versus those with hMPV detected in co-infection with other respiratory
viruses; the only difference we found was the diagnosis of bronchitis present in co-infected
patients (p = 0.0182) (Table 2).
Mild ARI was the most frequent presentation in all age groups analyzed. Bronchiolitis,
RDS, and RBO were diagnosed in children less than 12 months and asthma exacerbation
occurred in children between 1–14 years. HMPV in single infection was significantly more
prevalent in infants�12 month (p = 0.0007) and hMPV in co-infection was significantly more
prevalent in the 26–59 age group (p = 0.0439). In pediatric patients comorbidities were not
presented. No severe complications or deaths were related to hMPV.
Human Metapneumovirus genotypes
Optimal nucleotide sequences were obtained from 11 hMPV positive samples, 7 from N gene
and 4 from F gene. Table 3 shows the clinical and epidemiological features of patients whose
samples were sequenced.
Fig 2A shows ML tree based on F gene fragment, where the local strains analyzed were clus-
tered in hMPV A2 subtype, together with sequences previously reported in Argentina. The
Cordoba/ARG/2881/2011 strain is highly related to prototype strains from Canada, The Neth-
erlands, and Argentina. Cordoba/ARG/3064/2011 strains were more related to isolates from
the United States, China, and Nepal. Cordoba/ARG/2768/2011 and Cordoba/ARG/2895/2011
Table 2. Admitting diagnosis of 161 patients with hMPV single and co-infection.
Diagnosis at admission Total hMPV (n = 161) Single hMPV (n = 104) hMPV in co-infection (n = 57) p-value
Mild ARI 96 (59.6) 62 (59.6) 34 (59.6) 0.9967
Bronchiolitis 15 (9.3) 7 (6.7) 8 (14) 0.1273
Bronchitis 3 (1.83) 0 (0) 3 (5.3) 0.0182
Pneumonia 6 (3.7) 3 (2.9) 3 (5.3) 0.4461
RDS 7 (4.3) 5 (4.8) 2 (3.5) 0.6991
RBO 7 (4.3) 6 (5.8) 1 (1.75) 0.2322
Asthmatic crisis/Asthma exacerbation 6 (3.7) 4 (3.8) 2 (3.5) 0.9139
Influenza-like illness 6 (3.7) 2 (1.9) 4 (7) 0.1027
NA 15 (9.3) 15 (14.4) 0 (0) -
hMPV: human Metapneumovirus; ARI: Acute respiratory infection; RDS: Respiratory difficulty syndrome; RBO: Recurrent bronchial obstruction; NA: Not available
data.
https://doi.org/10.1371/journal.pone.0244093.t002
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Fig 2. Phylogenetic analysis of human metapneumovirus based on F and N genes. (A) F gene. A Maximum Likelihood
tree was constructed using the GTR+G model with parameters suggested by JModelTest 3.7 with bootstraps and 1000
pseudoreplicates. (B) N gene. A Maximum Likelihood tree was constructed using the TIM3+G model with parameters
suggested by JModelTest 3.7 with bootstraps and 1000 pseudoreplicates. A1: strains to subgroup A1 of hMPV. A2: strains
to subgroup A2 of hMPV. B1: strains to subgroup B1 of hMPV. B2: strains to subgroup B2 of hMPV. Avian MPV (aMPV)
was used to root the tree. The strains of interest are marked in bold. The scale bar indicates the changes between
nucleotides.
https://doi.org/10.1371/journal.pone.0244093.g002
Table 3. Demographic and clinical features of 11 patients with hMPV infection whose samples were sequenced and genotyped.
Strain ID Gender Agea Gene Sample date Clinical presentation
Cordoba/ARG/2590/2011 M 6 N April/2011 Mild ARI
Cordoba/ARG/2629/2011 F 8 N May/ 2011 Mild ARI
Cordoba/ARG/2708/2011 F 24 N June/2011 RDS
Cordoba/ARG/2768/2011 M 79 F July/2011 Mild ARI
Cordoba/ARG/2732/2011 M 24 N June/2011 Mild ARI
Cordoba/ARG/2755/2011 M 1 N July/2011 Mild ARI
Cordoba/ARG/2840/2011 F 6 N August/2011 Mild ARI
Cordoba/ARG/2895/2011 F 6 F August/2011 RBO
Cordoba/ARG/2881/2011 F 5 F August/2011 Mild ARI
Cordoba/ARG/2899/2011 M 5 N August/2011 Mild ARI
Cordoba/ARG/3064/2011 M 3 F December/2011 Pneumonia
All samples were nasopharyngeal swabs. ARI: Acute respiratory infection; RDS: Respiratory difficulty syndrome; RBO: Recurrent bronchial obstruction.
aMonth.
https://doi.org/10.1371/journal.pone.0244093.t003
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strains are closely related to each other, but Cordoba/ARG/2895/2011 presented more nucleo-
tide changes with an identity of 83% compared to the other local strains, which had 96–100%
identity among them.
Fig 2B shows ML tree based on N gene fragment. The Córdoba strains also were identified
as hMPV A2 and grouped with sequences from America and other regions. Cordoba/ARG/
2590/2011, Cordoba/ARG/2629/2011, Cordoba/ARG/2708/2011, Cordoba/ARG/2732/2011,
Cordoba/ARG/2755/2011, Cordoba/ARG/2840/2011, and Cordoba/ARG/2899/2011 strains
were clustered in one group related to strains from Brazil, Uruguay, and the United States.
Cordoba/ARG/2708/2011 strain presented 72–76% homology compared to other strains from
Cordoba identified in this study, which had 92–97% identity among them.
Discussion
This study describes for the first time the molecular epidemiology and genetic diversity of
hMPV infection and circulation in Cordoba, Argentina, during the years 2011–2013. This
agent caused ARI in children and adult patients and we detected 13.1% (104/795) hMPV as
single infection. Also, hMPV was detected in co-infections with other viruses in 7.2% (57/795)
of the patients. In terms of prevalence, hMPV was the second most frequently detected virus
after RSV (22.6%). Mild ARI were more frequent in all our groups studied. As reported by
other authors, in developing countries, ARI has a great impact on morbidity in the general
population and on morbidity/mortality in children and immunocompromised patients [23].
For this reason, viral infections such as hMPV responsible as causative agents of an important
proportion of ARI, need to be studied, surveyed, treated and controlled, as they are associated
with a substantial economic burden caused by hospitalizations and outpatient visits [24, 25].
Generally, hMPV prevalence varies between 4 and 22%, depending on the age group and
detection method [6, 19, 26, 27] however, few studies include elderly patients. In our study,
hMPV was detected in all age groups, being more prevalent in infants less than 12 month old
(24.3%) and among patients 15–26 years old (20%). Velez Rueda (2013) found similar preva-
lence in the pediatric population in our country [28], while it was detected in 11% of the chil-
dren under 5 years of age in the first report of hMPV in Argentina [15]. Other countries
including Mexico, Spain, and Brazil, have reported higher prevalence in the pediatric popula-
tion, reaching 20–25% [29–32]. Van den Hoogen (2003), reported higher prevalence in chil-
dren younger than 5 years old and detected cases in all age groups, even in subjects over 65
years old. In other countries, hMPV was detected in prevalence between 4 and 5% in adults
25–50 years old [30, 33]. Thus, hMPV is a frequent agent of ARI in subjects of all ages and re-
infections are common in children younger than 5 years of age, different than RSV, which is
more common in infants and children under 2 years [30, 34].
During the three years studied, we observed that hMPV had a higher incidence in August
2011 and 2012 and July of 2013, lasting until late spring. Thus, in Córdoba, hMPV is a preva-
lent respiratory agent in frank winter season, with cases occurring from the beginning of the
cold season throughout the spring. Human Metapneumovirus infections occur throughout the
year but the highest frequency of cases in the southern hemisphere occurs after the epidemic
peak of RSV [8]. Several studies highlight the typical distribution of this virus in early spring,
while circulation during summer seems to depend on local weather conditions [11, 15, 35, 36].
In this study, co-infection of hMPV with other viruses was detected in 35% (57/161) of
cases, along with RSV (61%), Flu-A (28%), PIV (5%), Flu-B (4%), and AdV (2%). These results
are in agreement with previous publications, in which a 35%-80% hMPV- RSV co-infection
rate has been reported, due to similar seasonal distribution [19, 35].
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With respect to the clinical presentation, the most common symptoms in our study were
fever, cough, and headache and the most frequent diseases were mild ARI, bronchiolitis, pneu-
monia, RDS, and RBO. Other authors have reported similar findings [30, 34, 35, 37] although
those studies also report symptoms like wheezing and dyspnea. Mild ARI was frequent in all
age groups studied, more prevalent in infants under 12 months. Generally, in the pediatric
population, the most frequent clinical presentations are bronchiolitis and pneumonia [15, 26,
28, 36]; in our study bronchiolitis only occurred in infants under 12 months. We found cases
of hMPV infection associated to asthma exacerbation in children under 14 years. This is
important because other authors have proposed that asthma exacerbation should be more
related to hMPV in comparison to RSV, mainly due to recurrent infections with different
virus subtypes [38], and hMPV infection was indeed associated with severe RBO as was
described in other studies [39].
Since the discovery of hMPV, two genotypes have been demonstrated: A and B [1]. We
identified the hMPV A2 subtype and our results showed that it circulated in Córdoba during
2011. We did not detect subtypes A1, B1 and B2; a reason for this may have been we were not
able to get high-quality RNA and/or optimal sequences from the years 2012 and 2013, how-
ever, other authors demonstrated that these subtypes are seldom reported [40]. In our country,
Galiano (2006) demonstrated the circulation of A1, A2 and B2 subtypes; Velez Rueda (2013)
showed that A2 and B2 subtypes co-circulated during 2009–2010, while hMPV A2 was detected
in 2011 [16, 28]. The local strains showed high homology to prototype strains from The Neth-
erlands, Canada, Argentina [16], and neighboring countries such as Uruguay [41], Brazil [42,
43], and Peru [44]. The high homology among some strains (93–100% identity) compared to
other strains (73–83% identity) from Córdoba identified in this study, indicates co-circulation
of strains with different genetic variability, which would predispose hMPV reinfections.
Limitations of our study need to be considered. This study was not including detection of
bacterial agents, human bocavirus, human coronaviruses, enteroviruses, and rhinoviruses. In
addition, the routine laboratory diagnosis in the clinical practice is still performed by immuno-
florescence assay, which is a technique with lower sensitivity compared to PCR (used here for
the detection of hMPV). On the other hand, balancing with this issue, we should mention that
the extremely high sensitivity of molecular methods inflict complexity to assigning the etiolog-
ical agent in many cases, as multiple co-infections are frequent due to the ability of these tech-
niques to detect the smallest amounts of nucleic acid of infecting agents. Taking all of these
into account, our analysis of the signs and symptoms associated to hMPV infection is useful as
an approximation to further focus on characterizing the clinical presentation of this virus in
single infection and when the viral load is high.
This study is the first report of hMPV in Córdoba. As we have shown a high prevalence in
hospitalized patients, we contribute to improving the diagnosis and treatment of acute respira-
tory infections by recommending its local routine detection and inclusion of hMPV in the
respiratory diagnostic panel. In this way we also contribute to the surveillance of respiratory
agents. These data allow us to expand our knowledge on hMPV in Córdoba, Argentina, and
future studies are justified to elucidate the clinical presentation of the infection and thus con-
tribute to a fitter handling of patients.
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S1 Table. Sequences available in the GenBank for both the N and F genes used for phyloge-
netic analysis.
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Writing – review & editing: Pamela Elizabeth Rodriguez, Marı́a Celia Frutos, Marı́a Pilar
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